Cancer Treatment Centers of America Leads Modern Cancer Treatment in the United States

Cancer Treatment Centers of America has partnered with All Scripts and NantHealth in order to provide even better cancer care treatment than ever before. CTCA and its new partners are going to create Clinical Pathways. Clinical Pathways supplies the physician with information about cutting-edge cancer treatment, proving the physician with unlimited options for treatment by eliminating any guesswork.

Cancer Treatment Centers of America was founded in 1988 in Schaumburg, Illinois by Richard J Stephenson who was dissatisfied with the cancer treatment his mother received prior to her death. He created this innovative cancer treatment so others in need of cancer treatment, get better care than Mrs. Stephenson did. Between 2005 and 2012, for CTCA hospitals were opened In addition to Zion, Illinois, there are treatment centers in Philadelphia, PA, Goodyear, AZ, Tulsa, Oklahoma, and Newman, Georgia. Two yeas ago, the headquarters of CTCA was moved to Boca Raton, Florida. It’s now known as Cancer Treatment Center of America Global.

Cancer Treatment Center of America is unique because the staff believes that every person with cancer is an individual. It is not just here’s the chemo and the radiation treatment. Cancer Treatment of America can use chemotherapy, but the staff also believes in putting patients on a special diet and creating an individual treatment plan. What might work for some patients may not work well for others.

According to Wikipedia, Cancer Treatment of America has better results than the country’s average. Breast Cancer patients thrive at 20 percent higher results than the country average. Five years after diagnosis prostate cancer averages seven points higher than average. After one year after diagnosis, prostate cancer patients average around 16 points higher success than the national average. In fact, most recently, CTCA is working with immunotherapy to help cancer patients be able to stop chemo treatments.

 

Leave a Reply